Ryah Medtech Inc, a wholly-owned subsidiary of PotBoitcs Inc, has added Michael Hart as vice president of business development, the company announced Monday.
Hart’s primary role will be gaining access to European and South American markets for the company’s namesake dose-measuring cannabis vaporizer.
Hart joins Ryah following a lengthy career in commercial sales. He has a proven history of business growth and bringing in both customers and partners, President and CEO Gregory Wagner said.
READ: PotBotics’ unit Ryah Medtech partners with Green Revolution to bring dose-measuring vaporizer to Washington state
“A highly-experienced business development executive with an impressive track record, Michael comes to us with a wealth of knowledge and quite an array of successes under his belt,” Wagner said. “He speaks several languages, shows excellent interpersonal skills and has vast marketing, business development, and consultative sales experience. He is also well-versed in financial forecasting and business planning and knows how to reach set targets”.
The RYAH vaporizer is able to precisely control dosage and monitor how much vapor users inhale. Its cartlidges have embedded QR codes that allows patients to track how different cannabis strains affect their symptoms. That data is fed into an AI platform that analyzes the relationship between cannabinoids and medical conditions.
“Ryah has made incredible headway in the medical cannabis market in the course of the last year, launching its products in several states in the US and taking steps to gain accreditation with Health Canada, to name but a few milestones,” Hart said. “It would be an understatement to say that it’s exciting to be joining the Ryah family at a time where medicinal cannabis is gaining worldwide attention and acceptance.”
Contact Andrew Kessel at [email protected]
Follow him on Twitter @andrew_kessel